NeuroMetrix Announces Diabetic Neuropathy Scientific Advisory Board WALTHAM, Mass., Mar 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it has formed a scientific advisory board of international experts to help guide the scientific, clinical and market development

NeuroMetrix to Present at Canaccord Genuity Musculoskeletal Conference WALTHAM, Mass., Feb 09, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that Shai N.

Strategic Focus on Diabetes; $17M Cash at Year-end 2010

NeuroMetrix, Inc. Announces Date for 2010 Fourth Quarter Financial Results Conference Call WALTHAM, Mass., Jan 26, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2010 fourth quarter financial results before the opening of the market on February 3, 2011.

Primary Focus on Diabetes